Develops multi-specific antibody therapeutics targeting dysregulated cellular signaling in severe chronic diseases using a proprietary platform.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Diagonal Therapeutics develops disease-modifying clustering antibody therapeutics that target dysregulated cellular signaling pathways at the root of chronic illnesses. The company uses a proprietary platform combining computational and experimental techniques to rapidly discover and optimize multi-specific antibodies for the treatment of severe diseases such as hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Diagonal Therapeutics Management Team
Investors
Atlas Venture Advisors Inc
Atlas Venture L.P.
Balyasny Asset Management
BVF Partners
BVF Partners LP
Deep Track Capital
EcoR1 Capital
Frazier Life Sciences Management, L.P.
Janus Henderson
Lightspeed Venture Partners
Logos Capital
RA Capital Management
Sanofi Ventures
Viking Global Investors
Woodline Partners LP
Diagonal Therapeutics Valuations & Financials
View real-time NPM data on Diagonal Therapeutics stock including daily Diagonal Therapeutics stock price estimates, valuation history, and historical share price information. Access Diagonal Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Diagonal Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Diagonal Therapeutics? Get in touch to learn more.
Similar Companies
like Diagonal Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Cambium
Climate & Sustainability
Engineers and produces extreme-environment materials using molecular design and agile manufacturing.
Inspirna
Discovers and develops novel cancer therapies targeting previously untreatable cancers using its proprietary RNA-DRIVEr™ platform.
Provenance
Media & Entertainment
Provides tools that help craft personalized vows, scripts, and toasts for meaningful ceremonies, alleviating stress and amplifying authenticity.
AI Squared
Simplifies and speeds up embedding AI models into business apps, enabling rapid deployment and actionable insights in daily workflows.
Vic.ai
AI & Machine Learning
Transforms accounting and finance processes using autonomy and intelligence to enhance productivity and decision-making.
Kiira Health
Connects young women to trusted health experts 24/7 via chat and video for primary care, OB/GYN, mental health, and more.
TalentBloom Healthcare
AI & Machine Learning
Streamlining hiring workflows that source clinical talent, automate interview feedback, and surface unbiased insights.
GoodTrust
Delivers an automated document generation framework that simplifies legacy planning through customizable legal directives and encrypted digital asset storage.
FAQ
We have answers
Diagonal Therapeutics stock does not trade on public stock exchanges. Diagonal Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Diagonal Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Diagonal Therapeutics Stock does not trade on public stock exchanges. In order to sell Diagonal Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Diagonal Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Diagonal Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Diagonal Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Diagonal Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Diagonal Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Diagonal Therapeutics is a private company and has not had an IPO. There is currently no Diagonal Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Diagonal Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
